FANZANI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 7.006
EU - Europa 3.713
AS - Asia 3.344
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 323
AF - Africa 76
OC - Oceania 14
Totale 14.948
Nazione #
US - Stati Uniti d'America 6.875
PL - Polonia 1.202
SG - Singapore 1.175
CN - Cina 1.091
IT - Italia 634
UA - Ucraina 514
BR - Brasile 389
DE - Germania 379
HK - Hong Kong 334
GB - Regno Unito 237
FI - Finlandia 236
VN - Vietnam 193
FR - Francia 148
IN - India 136
TR - Turchia 107
RU - Federazione Russa 99
IE - Irlanda 89
BD - Bangladesh 77
CA - Canada 64
JP - Giappone 45
MX - Messico 35
AR - Argentina 31
IQ - Iraq 30
ID - Indonesia 29
CZ - Repubblica Ceca 27
ES - Italia 24
NL - Olanda 24
SA - Arabia Saudita 21
SE - Svezia 21
ZA - Sudafrica 21
BE - Belgio 18
EG - Egitto 14
AU - Australia 13
AT - Austria 12
EC - Ecuador 12
CO - Colombia 11
UZ - Uzbekistan 11
VE - Venezuela 11
KE - Kenya 9
NG - Nigeria 9
CH - Svizzera 8
IR - Iran 8
KR - Corea 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
KZ - Kazakistan 7
MA - Marocco 7
AL - Albania 6
MY - Malesia 6
PA - Panama 6
JO - Giordania 5
PY - Paraguay 5
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
OM - Oman 4
PE - Perù 4
PH - Filippine 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
CL - Cile 3
CR - Costa Rica 3
HN - Honduras 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MU - Mauritius 3
PT - Portogallo 3
RO - Romania 3
SI - Slovenia 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
Totale 14.614
Città #
Warsaw 1.200
Ashburn 650
Fairfield 620
Singapore 618
Woodbridge 508
San Jose 458
Jacksonville 369
Hong Kong 331
Houston 309
Beijing 246
Cambridge 243
Seattle 235
Brescia 229
Chandler 218
Wilmington 218
New York 199
Ann Arbor 193
The Dalles 179
Los Angeles 160
Princeton 157
Chicago 133
Nanjing 132
Helsinki 129
Lauterbourg 92
Lancaster 91
Dublin 89
Istanbul 85
Columbus 77
Council Bluffs 76
Milan 72
Munich 66
Buffalo 65
Dearborn 62
Dallas 57
Jinan 56
Salt Lake City 55
Des Moines 54
Shenyang 51
Nanchang 48
Ho Chi Minh City 45
Hanoi 44
San Francisco 42
Shanghai 41
Hebei 38
Redondo Beach 36
Moscow 35
Tianjin 35
Dong Ket 34
Changsha 33
Elk Grove Village 31
Santa Clara 31
Turku 30
Verona 30
Orem 29
San Diego 28
Brooklyn 26
London 26
São Paulo 26
Denver 24
Jakarta 24
Phoenix 24
Rome 23
Boston 22
Tampa 22
Ningbo 20
Hangzhou 19
Atlanta 18
Taizhou 18
Brussels 17
Frankfurt am Main 17
Stockholm 17
Baghdad 16
Manchester 16
Nuremberg 16
Tokyo 16
Toronto 16
Johannesburg 15
New Delhi 15
Olomouc 15
Urbino 15
Zhengzhou 15
Chennai 14
Kunming 14
Montreal 14
Ottawa 14
Poplar 14
Salerno 14
Charlotte 13
Dhaka 13
Boardman 12
Mexico City 12
San Mateo 12
Taiyuan 12
Brno 11
Guangzhou 11
Lappeenranta 11
Miami 11
Norwalk 11
Sterling 11
Washington 11
Totale 10.125
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 597
Inhibition of glutathione peroxidase 4 primes mouse C2C12 myoblasts and rhabdomyosarcoma cell lines to ferroptosis 336
Characterization of the AP-1 μ1A and μ1B adaptins in zebrafish (Danio rerio) 315
Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma. 285
Caveolin-3, MURC and Trim72 predict myogenic differentiation in the human embryonal rhabdomyosarcoma RD cell line 284
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 272
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 262
Melatonin action in tumor skeletal muscle cells: an ultrastructural study 261
Intake of Special Amino Acids Mixture Leads to Blunted Murine Colon Cancer Growth In Vitro and In Vivo 251
Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma 230
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 222
Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways 211
Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma 204
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 204
Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes 197
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 197
Melatonin effects in normal and tumoral skeletal muscle cells: a preliminary study 196
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 195
Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines 193
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 189
Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems 186
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 186
Erastin is a strong inducer of ferroptosis in human rhabdomyosarcoma cell lines 179
The cytosolic sialidase Neu2 is degraded by autophagy during myoblast atrophy. 174
Caveolin-1-overexpression induces deep plasma membrane rearrangement and secretion of extracellular vesicles in a model of rhabdomyosarcoma 173
Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation. 172
Animal models of well-differentiated/dedifferentiated liposarcoma: utility and limitations 171
Implications for the mammalian sialidases in the physiopathology of skeletal muscle 170
Rhabdomyosarcomas: an overview on the experimental animal models. 169
Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts 166
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 166
CAVEOLIN-1 IS A MARKER OF POOR DIFFERENTIATION IN RHABDOMYOSARCOMA 166
Biochemical characterization of Neu2, a novel human cytosolic sialidase 158
Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression. 157
Autophagic degradation contributes to muscle wasting in cancer cachexia 157
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 157
The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy. 156
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. 156
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 156
Uncovering metabolism in rhabdomyosarcoma 156
Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation 154
Caveolins in rhabdomyosarcoma 152
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 149
Cavin-2 is a specific marker for detection of well-differentiated liposarcoma. 149
Molecular and cellular mechanisms of skeletal muscle atrophy: an update 146
Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy. 145
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 143
Focus on the role of Caveolin and Cavin protein families in liposarcoma 142
Validation of PTRF/cavin-1 expression and plasma membrane association with caveolin-1 in human cell lines and mouse primary tumor cultures of rhabdomyosarcoma 141
Caveolin-1-overexpression induces extracellular vesicle secretion in a model of rhabdomyosarcoma 141
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 139
Design and optimization of lentiviral vectors for transfer of galc expression in twitcher brain 138
Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell lines 138
AUTOPHAGIC DEGRADATION CONTRIBUTES TO MUSCLE WASTING IN CANCER CACHEXIA 136
OVEREXPRESSION OF CYTOSOLIC SIALIDASE NEU2 INDUCES MYOBLAST DIFFERENTIATION IN C2C12 CELLS 135
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas 135
CAVEOLINS AND CAVINS IN MUSCLE-DERIVED TUMOURS 134
Intracellular vesicular traffic:cloning, expression and antisense inhibition of AP1m1 subunit ortholog in zebrafish 131
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 131
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 130
Guidelines for the use and interpretation of assays for monitoring autophagy 127
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 127
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. 125
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 123
Generation and characterization of chemoresistant embryonal rhabdomyosarcoma RD line 120
IGF-I SIGNALING REGULATES CYTOSOLIC SIALIDASE NEU2 DURING MYOBLAST HYPERTROPHY. 120
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 118
Involvment of sialidases in differentation of PC12 117
The cytosolic sialidase Neu2 is substrate of degradation by autophagy during myoblast atrophy 112
IGF-I INDUCED HYPERTROPHY OF MYOBLASTS INCREASES CYTOSOLIC SIALIDASE NEU2 THROUGH PI-3 KINASE/AKT/mTOR PATHWAY. 109
The expression of Caveolin-3 and its related Limb Girdle Muscular Dystrophy 1-c mutants in myoblasts: physiological and pathological aspects 107
L6E9 Myoblasts Are Deficient of Myostatin and Additional TGF-βMembers Are Candidates to Developmentally Control Their FiberFormation 106
DORSOMORPHIN, A SELECTIVE INHIBITOR OF SMAD1/5/8 PHOSPHORYLATION, IS A POTENT ENHANCER OF MYOBLAST DIFFERENTIATION 106
Intracellular vesicular traffic: identification and expression of zebrafihs APM1 during zebrafish development 105
Developmental expression of the sialidase Neu2 ortholog gene in zebrafish and characterization of the knock-down model. 103
The chemotherapic compound cisplatin causes myotube atrophy by increment of proteasoma activation. 102
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and ERK signalling pathways 102
Downregulation of Zebrafish Cytosolic Sialidase Neu3.2 Affects Skeletal Muscle Development 101
INDUCTION OF MYOBLAST DIFFERENTIATION BY THE CYTOSOLIC SIALIDASE NEU2 OVEREXPRESSION 101
Nanostructured Hybrid Polymer-Lipid Drug Delivery Platforms for Rapamycin Repositioning in Anticancer Therapy 97
FUNCTIONAL ANTAGONISM BETWEEN P38 AND MYOSTATIN PATHWAYS IN RHABDOMYOSARCOMA CELLS 95
Expression of a myrystoilated Akt1 isoform in rhabdomyosarcoma cells promotes chemo and radioresistance, but confers marked susceptibility to metabolic drug inhibitors 89
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 89
THE MISSENSE CAV-3/P104L MUTATION, INVOLVED IN THE ONSET OF LIMB GIRDLE MUSCULAR DYSTROPHY 1-C, CONFERS AN IMMATURE SIGNATURE TO C2C12 MYOBLASTS 82
Essential Amino Acids-Rich Diet Decreased Adipose Tissue Storage in Adult Mice: A Preliminary Histopathological Study 82
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma 77
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 77
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 76
Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme 75
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 72
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 71
MS-275 (Entinostat) Promotes Radio-sensitivity in PAX3-FOXO1 Rhabdomyosarcoma cells 69
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 69
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204 64
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo 62
Radioresistance in rhabdomyosarcomas: Much more than a question of dose 58
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 56
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 56
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 55
Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines 39
Totale 14.882
Categoria #
all - tutte 62.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022657 0 128 20 14 6 22 48 37 27 97 95 163
2022/2023693 87 24 31 41 60 165 5 63 112 10 39 56
2023/2024817 55 13 108 41 42 159 26 43 177 21 15 117
2024/20252.339 39 10 32 254 197 138 144 62 245 104 832 282
2025/20264.117 405 470 228 511 497 280 696 197 244 332 183 74
2026/2027161 152 9 0 0 0 0 0 0 0 0 0 0
Totale 14.948